Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gentec is a private Spanish pharmaceutical company operating as Gentec Pharmaceutical Group, focused primarily on the manufacture and commercialization of active pharmaceutical ingredients (APIs), including HPAPIs, rather than on a therapeutic drug pipeline. The company also provides contract manufacturing and pharmaceutical development services through affiliated units, including API/intermediate manufacturing and formulation, analytical, stability, and dossier support. In addition to pharmaceutical ingredients, Gentec supplies selected raw materials for the food and nutrition industries. Its commercial footprint includes offices in Spain, India, China, Brazil, and Mexico, with distribution and partnership activity spanning more than 50 countries. Overall, Gentec appears to be a healthcare-related manufacturing and services company with a commercial-stage API and pharma services business, not a clinical-stage biotech innovator.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gentec.